An international team of researchers led by Karolinska Institutet in Sweden reports that cells in the central nervous system known as oligodendrocytes might have a different role in the development of multiple sclerosis (MS) ...
Feb 4, 2022
0
28
The concept of new bone formation via divalent cations is widely reported although the underlying mechanism of the process remains unclear. In a new report now published in Nature Communications, Wei Qiao and a team of scientists ...
Severe and persistent disability often undermines the life-saving benefits of cancer treatment. Pain and fatigue—together with sensory, motor, and cognitive disorders—are chief among the constellation of side effects ...
Jan 8, 2022
0
163
In an observational study conducted across three pediatric intensive care units (PICUs) in England over a three-month period in 2019, one-sixth of patients experienced at least one adverse drug event, in which they were harmed ...
Dec 8, 2021
0
7
Researchers from The Australian National University (ANU) have identified unique molecular signals in the body that could hold the key to developing a supplement capable of administering the health benefits of exercise to ...
Dec 1, 2021
0
43
Glial cells in the heart help regulate heart rate and rhythm, and drive its development in the embryo, according to a new study publishing November 18th in the open-access journal PLOS Biology by Nina Kikel-Coury, Cody Smith ...
Nov 18, 2021
0
47
Neuroimmune interactions are emerging as key regulators of brain plasticity throughout life and in both health and disease, but much remains to be discovered. In a special issue of Brain Plasticity, experts review our present ...
Nov 16, 2021
0
54
Osteocalcin (OCN) is a multifunctional bone-derived hormone that modulates numerous physiological activities. OCN can cross the blood brain barrier (BBB) and thus play critical roles in neuronal and brain development.
Oct 22, 2021
0
367
A spinal cord injury damages the lines of communication between the body and brain, impeding the signals that drive movement and sensation. Injured motor and sensory neurons in the central nervous system—the brain and spinal ...
Oct 19, 2021
0
199
In a phase II clinical trial, the drug 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) improved survival for some adolescent and young adult (AYA) patients with cancers involving the central nervous system, ...
Oct 7, 2021
0
2
